Activation Switch in the Transmembrane Domain of Metabotropic Glutamate Receptor

Metabotropic glutamate receptors (mGluRs), members of family 3 G protein-coupled receptors, play pivotal roles in the modulation of synaptic transmission and are important drug targets for various neurological diseases. The structures of the extracellular ligand-binding domain (ECD) of mGluRs and its changes upon ligand binding have been well studied by various techniques, including X-ray crystallography. In contrast, little is known about the structure and structural changes of the seven-transmembrane domain (TMD). Here we searched for constitutively active mutation (CAM) sites in the TMD of mGluR8 to get insight into the epicenter of the structural changes in TMD, a potential target for allosteric ligands. Mutational analyses based on the knowledge of activating mutations of calcium-sensing receptor showed the presence of several CAM sites in the TMD of mGluR8. Among them, the site at position 764 in helix V, where threonine is present, is unique in that any substitution resulted in elevation of the basal activity, and some substitutions caused a loss of responsiveness to agonist. Further comprehensive mutational analyses indicated that the additional mutation of the CAM site at position 663 in helix III, where a tyrosine residue is present, generated a revertant phenotype. Mutations at these sites also increased the agonist binding affinity, although these sites are far from the ECD. These results indicated that the specific pair of amino acids at these CAM sites forms an activation switch that stabilizes the inactive state of mGluR8 and mediates the signal flow from the ECD to the cytoplasmic G protein-interacting site.

[1]  Yoshihiro Kubo,et al.  Ligand-induced rearrangement of the dimeric metabotropic glutamate receptor 1α , 2004, Nature Structural &Molecular Biology.

[2]  Patrick Scheerer,et al.  Crystal structure of the ligand-free G-protein-coupled receptor opsin , 2008, Nature.

[3]  A. Terakita,et al.  The second cytoplasmic loop of metabotropic glutamate receptor functions at the third loop position of rhodopsin. , 2001, Journal of biochemistry.

[4]  J. Kew,et al.  Mutational Analysis and Molecular Modeling of the Allosteric Binding Site of a Novel, Selective, Noncompetitive Antagonist of the Metabotropic Glutamate 1 Receptor* , 2003, The Journal of Biological Chemistry.

[5]  R. Lefkowitz,et al.  A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.

[6]  N. Kunishima,et al.  Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+ , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Manfred Burghammer,et al.  Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. , 2007, Nature.

[8]  A. Dilella,et al.  Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Kenneth A Jacobson,et al.  A Region in the Seven-transmembrane Domain of the Human Ca2+ Receptor Critical for Response to Ca2+* , 2005, Journal of Biological Chemistry.

[10]  Rob Leurs,et al.  Pharmacogenomic and structural analysis of constitutive g protein-coupled receptor activity. , 2007, Annual review of pharmacology and toxicology.

[11]  P. Malherbe,et al.  Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine. , 2003, Molecular pharmacology.

[12]  T. Knöpfel,et al.  The Second Intracellular Loop of Metabotropic Glutamate Receptor 1 Cooperates with the Other Intracellular Domains to Control Coupling to G-proteins (*) , 1996, The Journal of Biological Chemistry.

[13]  R. Stevens,et al.  GPCR Engineering Yields High-Resolution Structural Insights into β2-Adrenergic Receptor Function , 2007, Science.

[14]  Willem Soudijn,et al.  Allosteric modulation of G-protein-coupled receptors , 2001 .

[15]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[16]  A. Spiegel,et al.  Naturally occurring mutations of the extracellular Ca2+-sensing receptor: implications for its structure and function , 2003, Trends in Endocrinology & Metabolism.

[17]  L. Pardo,et al.  Constitutively Active Mutants of the Histamine H1 Receptor Suggest a Conserved Hydrophobic Asparagine-Cage That Constrains the Activation of Class A G Protein-Coupled Receptors , 2008, Molecular Pharmacology.

[18]  A. Terakita,et al.  Conformational change of the transmembrane helices II and IV of metabotropic glutamate receptor involved in G protein activation , 2008, Journal of neurochemistry.

[19]  M. Burghammer,et al.  Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.

[20]  Takanori Muto,et al.  Structures of the extracellular regions of the group II/III metabotropic glutamate receptors , 2007, Proceedings of the National Academy of Sciences.

[21]  R. Duvoisin,et al.  Role of the Second and Third Intracellular Loops of Metabotropic Glutamate Receptors in Mediating Dual Signal Transduction Activation* , 1998, The Journal of Biological Chemistry.

[22]  D. Filliol,et al.  Opioid receptor random mutagenesis reveals a mechanism for G protein–coupled receptor activation , 2003, Nature Structural Biology.

[23]  H Weinstein,et al.  Functional role of a conserved motif in TM6 of the rat mu opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp. , 2001, Biochemistry.

[24]  S. Mosolov,et al.  Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial , 2007, Nature Medicine.

[25]  S. Nakanishi,et al.  Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor , 2000, Nature.

[26]  G. Liapakis,et al.  Constitutive Activation of the β2 Adrenergic Receptor Alters the Orientation of Its Sixth Membrane-spanning Segment* , 1997, The Journal of Biological Chemistry.

[27]  Harel Weinstein,et al.  Conserved Helix 7 Tyrosine Acts as a Multistate Conformational Switch in the 5HT2C Receptor , 2002, The Journal of Biological Chemistry.

[28]  D. Oprian,et al.  Constitutive activation of opsin: influence of charge at position 134 and size at position 296. , 1993, Biochemistry.

[29]  Yoshinori Shichida,et al.  Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Pin,et al.  Activation of a Dimeric Metabotropic Glutamate Receptor by Intersubunit Rearrangement* , 2007, Journal of Biological Chemistry.

[31]  Andrzej Pilc,et al.  An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats , 2007, Amino Acids.

[32]  A. Terakita,et al.  A novel constitutively active mutation in the second cytoplasmic loop of metabotropic glutamate receptor , 2004, Journal of neurochemistry.

[33]  Oliver P. Ernst,et al.  Crystal structure of opsin in its G-protein-interacting conformation , 2008, Nature.

[34]  Y. Tsukahara,et al.  Light-modulated subcellular localization of the alpha-subunit of GTP-binding protein Gq in crayfish photoreceptors , 1996, Visual Neuroscience.

[35]  R. Duvoisin,et al.  A novel metabotropic glutamate receptor expressed in the retina and olfactory bulb , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  M. Caron,et al.  Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. , 1992, The Journal of biological chemistry.